Leerink Partnrs Has Optimistic Outlook of Zoetis Q3 Earnings

Zoetis Inc. (NYSE:ZTS) – Research analysts at Leerink Partnrs boosted their Q3 2025 earnings per share estimates for Zoetis in a research report issued on Thursday, July 17th. Leerink Partnrs analyst D. Clark now anticipates that the company will earn $1.69 per share for the quarter, up from their prior estimate of $1.68. Leerink Partnrs currently has a “Hold” rating on the stock. The consensus estimate for Zoetis’ current full-year earnings is $6.07 per share. Leerink Partnrs also issued estimates for Zoetis’ Q3 2025 earnings at $1.69 EPS and FY2025 earnings at $6.25 EPS.

Several other research firms have also commented on ZTS. Leerink Partners lowered Zoetis from an “outperform” rating to a “market perform” rating and dropped their target price for the company from $180.00 to $155.00 in a report on Thursday. Stifel Nicolaus lowered Zoetis from a “buy” rating to a “hold” rating and dropped their target price for the company from $165.00 to $160.00 in a report on Wednesday, June 18th. UBS Group dropped their target price on Zoetis from $189.00 to $170.00 and set a “neutral” rating on the stock in a report on Wednesday, May 7th. Finally, Piper Sandler increased their target price on Zoetis from $205.00 to $210.00 and gave the company an “overweight” rating in a report on Monday, May 12th. Four equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Zoetis presently has a consensus rating of “Moderate Buy” and an average price target of $204.63.

Zoetis Stock Down 0.9%

Zoetis stock opened at $148.61 on Friday. Zoetis has a twelve month low of $139.70 and a twelve month high of $200.33. The stock’s fifty day simple moving average is $160.77 and its 200-day simple moving average is $161.44. The company has a current ratio of 1.74, a quick ratio of 1.04 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $66.16 billion, a P/E ratio of 26.68, a P/E/G ratio of 2.49 and a beta of 0.91.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The business had revenue of $2.22 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same quarter in the prior year, the company earned $1.38 earnings per share. The company’s revenue was up 1.4% on a year-over-year basis.

Hedge Funds Weigh In On Zoetis

Several hedge funds have recently made changes to their positions in the company. HUB Investment Partners LLC grew its holdings in shares of Zoetis by 4.7% during the fourth quarter. HUB Investment Partners LLC now owns 1,373 shares of the company’s stock worth $224,000 after purchasing an additional 62 shares during the last quarter. Coppell Advisory Solutions LLC grew its holdings in shares of Zoetis by 18.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 420 shares of the company’s stock worth $68,000 after buying an additional 64 shares during the last quarter. Lindbrook Capital LLC grew its holdings in shares of Zoetis by 1.8% during the first quarter. Lindbrook Capital LLC now owns 3,715 shares of the company’s stock worth $612,000 after buying an additional 65 shares during the last quarter. Scott & Selber Inc. grew its holdings in shares of Zoetis by 0.6% during the second quarter. Scott & Selber Inc. now owns 11,652 shares of the company’s stock worth $1,817,000 after buying an additional 67 shares during the last quarter. Finally, Secure Asset Management LLC grew its holdings in shares of Zoetis by 2.9% during the second quarter. Secure Asset Management LLC now owns 2,448 shares of the company’s stock worth $382,000 after buying an additional 68 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Insider Activity

In other Zoetis news, EVP Roxanne Lagano sold 652 shares of the firm’s stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total transaction of $110,840.00. Following the transaction, the executive vice president owned 15,129 shares of the company’s stock, valued at approximately $2,571,930. This trade represents a 4.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.18% of the company’s stock.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.35%. The ex-dividend date is Friday, July 18th. Zoetis’s payout ratio is 35.91%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.